Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $225.64 million. The enterprise value is $736.56 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 160.03 million shares outstanding. The number of shares has increased by 16.64% in one year.
| Current Share Class | 160.03M |
| Shares Outstanding | 160.03M |
| Shares Change (YoY) | +16.64% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 75.40% |
| Float | 121.87M |
Valuation Ratios
The trailing PE ratio is 141.00 and the forward PE ratio is 8.13.
| PE Ratio | 141.00 |
| Forward PE | 8.13 |
| PS Ratio | 0.73 |
| Forward PS | 0.79 |
| PB Ratio | -0.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 406.27 |
| EV / Sales | 2.10 |
| EV / EBITDA | 7.40 |
| EV / EBIT | 7.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.66
| Current Ratio | 4.66 |
| Quick Ratio | 4.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.80 |
| Debt / FCF | n/a |
| Interest Coverage | 2.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 14.81% |
| Return on Invested Capital (ROIC) | 18.25% |
| Return on Capital Employed (ROCE) | 31.22% |
| Revenue Per Employee | $1.32M |
| Profits Per Employee | $6,790 |
| Employee Count | 267 |
| Asset Turnover | 0.85 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $64.47 million in taxes.
| Income Tax | 64.47M |
| Effective Tax Rate | 97.26% |
Stock Price Statistics
The stock price has decreased by -83.64% in the last 52 weeks. The beta is 0.37, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -83.64% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 4.12 |
| Relative Strength Index (RSI) | 33.76 |
| Average Volume (20 Days) | 2,927,254 |
Short Selling Information
The latest short interest is 10.70 million, so 6.69% of the outstanding shares have been sold short.
| Short Interest | 10.70M |
| Short Previous Month | 10.75M |
| Short % of Shares Out | 6.69% |
| Short % of Float | 8.78% |
| Short Ratio (days to cover) | 6.49 |
Income Statement
In the last 12 months, IRWD had revenue of $351.41 million and earned $1.81 million in profits. Earnings per share was $0.01.
| Revenue | 351.41M |
| Gross Profit | 241.46M |
| Operating Income | 97.44M |
| Pretax Income | 88.16M |
| Net Income | 1.81M |
| EBITDA | 99.48M |
| EBIT | 97.44M |
| Earnings Per Share (EPS) | $0.01 |
Full Income StatementBalance Sheet
The company has $88.56 million in cash and $599.48 million in debt, giving a net cash position of -$510.92 million or -$3.19 per share.
| Cash & Cash Equivalents | 88.56M |
| Total Debt | 599.48M |
| Net Cash | -510.92M |
| Net Cash Per Share | -$3.19 |
| Equity (Book Value) | -301.25M |
| Book Value Per Share | -1.89 |
| Working Capital | 143.27M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 68.71%, with operating and profit margins of 27.73% and 0.52%.
| Gross Margin | 68.71% |
| Operating Margin | 27.73% |
| Pretax Margin | 18.86% |
| Profit Margin | 0.52% |
| EBITDA Margin | 28.31% |
| EBIT Margin | 27.73% |
| FCF Margin | n/a |